MedPath

A novel way in treatment of chronic plantar fasciitis: Combination of Extracorporeal shock wave therapy and topical corticosteroid with occlusive dressing

Not Applicable
Conditions
Plantar Fasciitis.
Plantar fascial fibromatosis
Registration Number
IRCT2016081029296N1
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Age>18 y; Disease duration more than 6 months; Not responsive to conservative treatment; Exclusion criteria : Age less than 18 ;Open growth plate; pregnancy; bone tumor or other malignancy near treatment site; metabolic disease; open wound; Received systemic corticosteroid within the last month; Received topical corticosteroid in plantar fascia region within the last 6 weeks; Active infection; Skin disease; peripheral neuropathy; coagulopathy disorder; received heparin or warfarin; Past history of plantar ligament rupture; Past history of surgery in this region; vascular disease; Allergic reaction to sulfonamide, NSAID or Aspirin; Heart failure; tarsal tunnel syndrome

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: before intervention /1 month and 3 months after intervention. Method of measurement: Visual Analogue Scale.;Modified Roles and Maudsley score. Timepoint: before intervention /1 month and 3 months after intervention. Method of measurement: Modified Roles and Maudsley Scale.
Secondary Outcome Measures
NameTimeMethod
Plantar fascia thickness. Timepoint: before and 3 months after intervention. Method of measurement: sonography.
© Copyright 2025. All Rights Reserved by MedPath